Sequencing Reagents Market Size & Share, By Type (Template Kits, Library Kits, Control Kits, Sequencing Kits); Technology (Next Generation Sequencing, Sanger Sequencing, Third Generation Sequencing); Application (Clinical Investigation, Oncology, Forensics & Agrigenomics, Virology, RNA Sequencing, Metagenomics); Reagent Type (DNTP, DNA Polymerase, Ampicillin, Buffer Solution, NGS, Serum Kits) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5883
  • Published Date: Mar 18, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Sequencing Reagents Market size is expected to reach USD 14 Billion by the end of 2036, growing at a CAGR of 14% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of sequencing reagents was USD 6 Billion. The quick development in sequencing technology will primarily propel the market of market by the end of 2036. Illumina sequencing creation, sequencing by blend (SBS), may be an extensively approved next-generation sequencing (NGS) creation across the globe. Illumina sequencing instruments and reagents back considerably parallel sequencing utilizing an exclusive plan that acknowledges single bases as they are connected into growing DNA strands.

Another reason behind the massive growth of the sequencing reagents market is the limited costs of genetic sequencing. The HGP included beginning with mapping and after that sequencing the human genome. The previous was required at the time since there was something else no 'framework' for organizing the real sequencing or the coming about arrangement information. The maps of the human genome served as 'scaffolds' on which to put through personal portions of amassed DNA grouping. These genome-mapping endeavors were very costly but were basic at the time for producing an exact genome arrangement. It is troublesome to appraise the costs related to the 'human genome mapping phase' of the HGP, but it was certainly within the numerous tens of millions of dollars. The evaluation has taken a toll on creating that beginning 'draft' human genome arrangement is approximately USD 300 million around the world, of which NIH generally has 50-60%.


Sequencing Reagents Market
Get more information on this report: Request Free Sample PDF

Sequencing Reagents Market: Growth Drivers & Challenges

Growth Drivers

  • Increasing technological Modifications in Sequencing Technology - The sequencing scene has significantly changed over the final few a long time. With the critical drop in sequencing costs and the presentation of imaginative disobedient organizations, opting for a suitable sequencer has ended up an increasingly intricate errand. Oxford Nanopore Innovations (ONT) offers a one-of-a-kind approach to sequencing by specifically perusing DNA or RNA arrangements through nanopores. This empowers the discovery of basic variations such as single nucleotide variations, but moreover, more complex ones counting auxiliary variety and methylation, all from a single test. The ease of library arrangement and their non-reliance on complex optical frameworks makes them open and reasonable innovations, clarified Rosemary Sinclair Dokos, SVP of Item and Program Administration at Oxford Nanopore Innovations. The increasing prevalence of DNA digital data storage systems will also help in advancing the sequencing reagents market.
  • Increasing Existence of Supporting Government Programs of Genome Sequencing - Here, genomics is becoming a principal apparatus in the understanding of well-being and malady movement. The world-leading genomic framework that the UK has created has put it at the head of genomic information capacity and inquired about globally. Genomics is anticipated to make a central column of future UK well-being benefit conveyance by the NHS. Subsidizing came from the Joined together States government through the National Organizing of Wellbeing (NIH) as well as various other bunches from around the world. Most of the government-sponsored sequencing was performed in twenty universities and investigation centers within the Joined together States, the United Kingdom, Japan, France, Germany, and China, working within the Universal Human Genome Sequencing Consortium (IHGSC).
  • Rising Investment of Private and Public Bodies - Each genome has roughly 3.2 billion DNA base sets, and the way they are organized, or varieties and transformations in their design, can give clues about the individual's well-being or sick well-being, acquired or obtained. In any case, there has not been an appraisal of either the current accessibility of NGS or the method for creating a strong proof base. 

Challenges

  • Shortage of Gerome Sequencing Resources in Growing Countries - The intriguing field of DNA sequencing requires an understanding of bioinformatics, chemistry, and science. As a result, people who embrace DNA sequencing require specific preparation. Also, researchers can utilize capable computational and factual strategies to translate the useful data bolted in DNA arrangements much appreciated to the consideration of genomic information science. These information science strategies are utilized within the field of genomic medication to help analysts and clinicians understand how varieties in DNA affect human well-being and illness. The utilization of numerous modern instruments still requires the installment of permit expenses, which are regularly out of the budgetary reach of numerous teachers in creating nations, indeed even though a few devices are given beneath open-source licenses. As a result, one of the greatest deterrents to industry development is the need for assets, such as sequencing reagents for DNA sequencing, in destitute countries.
  • Shortage of Advantageous Compensation Policies
  • Increase in Regulatory Appearance for Next-Generation Sequencing Processes

Sequencing Reagents Market: Key Insights

Base Year

2023

Forecast Year

2036

CAGR

∼14%

Base Year Market Size (2023)

~USD 6 Billion

Forecast Year Market Size (2036)

~USD 14 Billion

Regional Scope

  • North America (North America, Canada, Mexico)
  • Europe (Germany, Spain, UK, France, Italy, Russia, Others)
  • Asia Pacific (Japan, China, India, Australia, Others)
  • Middle East and Africa (South Africa, UAE, Others)
  • Latin America (Brazil, Argentina, Others)
Get more information on this report: Request Free Sample PDF

Sequencing Reagents Segmentation

Technology (Next Generation Sequencing, Sanger Sequencing, Third Generation Sequencing)

The next-generation sequencing segment in the will grow the most by the forecast period and will hold almost 45% in the sequencing reagents market because of its high possibility for the growth of companion diagnostics and customized medicine for the treatment of chronic diseases. Next-generation sequencing (NGS) may empower more centered and profoundly personalized cancer treatment, with the National Comprehensive Cancer Arrange and European Society for Restorative Oncology rules presently prescribing NGS for everyday clinical hone for a few tumor sorts. Be that as it may, NGS usage, and thus persistent get to, changes over Europe; a multi-stakeholder collaboration is required to set up the conditions required to progress this disparity. In that respect, the analysts set up European Collusion for Customized Pharmaceutical (EAPM)-led master boards amid the primary half of 2021, counting key partners from over 10 European countries covering restorative, financial, quiet, industry, and legislative mastery. NGS tests are ordinarily run to realize a foreordained scope, which is the normal profundity of sequencing overall focused on genome positions. Scope at any genome arrangement can be calculated, after mapping sequencing peruses to the reference genome, by tallying the number of autonomous peruses that cover that position and thus will propel the sequencing reagents market.

Application (Clinical Investigation, Oncology, Forensics & Agrigenomics, Virology, RNA Sequencing, Metagenomics)

The oncology segment is expected to hold around 38% share of the global sequencing reagents market by 2036, owing to the increasing implementation of next-generation sequencing for cancer diagnosis and treatment across the world. Next-generation sequencing testing selection rates have expanded in later a long time, with rates for progressed non–small cell lung cancer (aNSCLC), metastatic colorectal cancer (mCRC), metastatic breast cancer (mBC), and progressed melanoma expanding from less than 1% in 2011 to approximately 40% in 2022. Thus, it will help this segment to have the largest growth in the sequencing reagents market.

Our in-depth analysis of the global sequencing reagents market includes the following segments:

     Type

  • Template Kits
  • Library Kits
  • Control Kits
  • Sequencing Kits

     Technology

  • Next Generation Sequencing
  • Sanger Sequencing
  • Third Generation Sequencing

     Application

  • Clinical Investigation
  • Oncology
  • Forensics & Agrigenomics
  • Virology
  • RNA Sequencing
  • Metagenomics

     Reagent Type

  • DNTP Reagent
  • DNA Polymerase Reagent
  • Ampicillin Reagent
  • Buffer Solution Reagent
  • NGS Reagent
  • Serum Reagent Kits

     End-Use Industry

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Sequencing Reagents Industry - Regional Synopsis

North American Market

The sequencing reagents market in the North America region will have the biggest growth during the forecast period with a revenue share of around 34%. This growth will be noticed owing to the region’s advanced healthcare system. The Joined together States positions 4th in the World Record of Healthcare Development, with an in-general score of 54.96, behind as it were Switzerland, Germany, and the Netherlands. Americans are as a rule the primary to pick up major unused therapeutic propels, progresses regularly found at American colleges and created by American companies. As a result, the U.S. positioned to begin with for both Choice (57.67) and Science & Innovation (75.15).

European Market

The sequencing reagents market in the Europe region will also encounter huge growth during the forecast period and will hold the second position owing to the rising concentration on customized medicine and high healthcare investment in countries like the United Kingdom and Germany. With its 743 million inhabitants spread over 44 nations, counting the 27 countries inside the EU, Europe may be a critical player within the worldwide financial landscape. Moreover, by 2040 care will be sorted out around the citizens instead of around the teachers that drive the existing healthcare frameworks. These changes will influence the businesses and working models of all partners, counting unused non-traditional companies entering the healthcare space. Thus, it will help the European region to have significant growth in the sequencing reagents market.

Research Nester
Sequencing Reagents Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Sequencing Reagents Market

top-features-companies
    • Thermo Fisher Scientific, Inc.
      • Company Overview
      • Business Planning
      • Main Product Offerings
      • Financial Execution
      • Main Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Illumina, Inc.
    • QIAGEN
    • BGI
    • Pacific Biosciences of California, Inc.
    • F. Hoffmann-La Roche A.G.
    • Oxford Nanopore Technologies
    • Agilent Technologies, Inc.
    • Fluidigm Corporation
    • ArcherDX, Inc.

In-the-news

In The News

Total Genomics, the US backup of Chinese next-generation sequencing instrumented organization MGI Tech, disclosed its most noteworthy throughput sequencer at the yearly assembly of Propels in Genome Science and Innovation.

Thermo Fisher Scientific Inc, the world pioneer in serving science, recently reported the dispatch of an unused CorEvitas syndicated clinical registry in generalized pustular psoriasis (GPP). This registry, which is open to enrollment, is CorEvitas' 10th syndicated illness registry and addresses a neglected requirement for real-world proof (RWE) related to the clinical and patient-reported results of patients with GPP.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5883
  • Published Date: Mar 18, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The quick development in sequencing technology will majorly drive the growth of the sequencing reagents market.

The market size of the sequencing reagents market is expected to get a CAGR of approximately 14% over the forecast period, i.e., 2024-2036.

The major players in the market are Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, BGI, Pacific Biosciences of California, Inc., F. Hoffmann-La Roche A.G., Oxford Nanopore Technologies, Agilent Technologies, Inc., Fluidigm Corporation, ArcherDX, Inc., Myriad Genetics. Inc., Eurofins Scientific, Takara Bio Inc., Mitsui Information Co., Ltd.

The oncology segment is anticipated to reap the largest market size with almost 38% by the end of 2036 and demonstrate substantial growth scopes.

The market in the North American region is expected to have the largest market share by the end of 2036 and provide more business opportunities in the future.
Sequencing Reagents Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying